Relative Adrenal Insufficiency is Associated with the Clinical Outcome in Patients with Stable Decompensated

Evangelos Cholongitas1, Ioannis Goulis1, Eirini Pagkalidou2

  • 14th Department of Internal Medicine, Hippokration General Hospital, Medical School Aristotle University of Thessaloniki, Greece.

Annals of Hepatology
|June 15, 2017
PubMed

Insights

Relative adrenal insufficiency (AI) in patients with stable decompensated cirrhosis (DeCi) is linked to circulatory issues and a higher risk of death. This study highlights the clinical impact of AI on DeCi outcomes, emphasizing its association with worse survival.

Area of Science:

  • Endocrinology
  • Hepatology
  • Critical Care Medicine

Background:

  • The clinical significance of relative adrenal insufficiency (AI) in patients with stable decompensated cirrhosis (DeCi) remains unclear.
  • AI is a potential complication in liver disease, affecting hormonal balance and physiological responses.

Purpose of the Study:

  • To investigate the association between AI and patient outcomes, specifically death or liver transplantation (LT), in individuals with DeCi.
  • To identify clinical and laboratory factors associated with AI in this patient population.

Main Methods:

  • A cohort of 113 patients with stable DeCi and no active complications were assessed.
  • Salivary cortisol (SC) and serum total cortisol (STC) were measured at baseline and 1 hour post-corticotropin injection.
  • Clinical data, including blood pressure, serum electrolytes, lipids, albumin, bilirubin, and history of spontaneous bacterial peritonitis (SBP), were collected.

Main Results:

  • 30% of patients (n=34) were diagnosed with AI.
  • AI patients exhibited lower systolic blood pressure, serum sodium, HDL, and albumin, with higher direct bilirubin compared to non-AI patients.
  • A history of SBP was significantly more frequent in patients with AI (29.4% vs. 7.5%).
  • AI was independently associated with an increased risk of death (HR=2.65, p=0.003) over a median follow-up of 12 months.

Conclusions:

  • Relative adrenal insufficiency is prevalent in stable decompensated cirrhosis and is associated with significant clinical implications.
  • AI in DeCi patients correlates with circulatory dysfunction, a history of SBP, and poorer survival rates.
  • These findings underscore the importance of evaluating adrenal function in patients with DeCi to potentially improve patient management and prognosis.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.6K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
302
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
964
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
567